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The thesis entitled “Synthetic studies on R207910, aza-Diospongin A and 
hydroxylamine derivatives” is divided into three chapters. 
Chapter I: Chapter I is divided into two sections. 
Section A: Introduction to Tuberculosis and the drugs available for treatment. 
Section B: Describes the practical synthesis of anti-TB clinical molecule (2S)-R207910 
and its (2R) isomer. 
Chapter II: Deals with the introduction to analogues and asymmetric synthesis of aza (-)-
Diospongin A as an iNOS inducer. 
Chapter III: Describes the Palladium-catalyzed addition of hydroxylamine derivatives to 
Baylis–Hillman acetate adducts. 
------------------------------------------------------------------------------------------------------------- 
Chapter I 
Section A: Introduction to Tuberculosis and the drugs available for treatment. 
Tuberculosis (TB) is a deadly infectious disease caused by Mycobacterium 
tuberculosis (MTb). It is primarily an infirmity of the respiratory system and is spread 
through air via coughing and sneezing of the infected person. In conjunction with the 
spread of HIV infection, tuberculosis is today amongst the worldwide health intimidations. 
Nearly 1/3
rd
 of world’s population has been infected with Mtb. Globally 9.2 million new 
cases and 1.7 million deaths occur every year albeit widespread vaccination and 
chemotherapy.
 
As a result, TB has become a major health and socioeconomic problem in 
most of the countries. Although the treatment with current first line drugs: isoniazid (1), 
rifampicin (2) and pyrazinamide (3) and ethambutol (4) (Fig 1) was able to cure most of 
the disease, a major problem in TB treatment is the development of multidrug-resistant 
tuberculosis (MDR-TB), which can be defined as strains that are resistant to at least 
isoniazid (1) and rifampicin (2), two
 
important first line drugs used in TB treatment. 
Another serious problem, in the context of MDR-TB, is the emergence of extensively 
drug-resistant tuberculosis (XDR-TB), which can be defined as strains resistant to first and 
second line anti-TB drugs. As a consequence many second line drugs were discovered and  
used in the treatment depending upon the diagnosis and patient response. But present 
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Figure 1 
situation demands a continuous need of new drugs, which can cure all the active, latent and 
resistant forms with novel mechanism of action.  
Section B: Practical synthesis of anti-TB clinical molecule (2S)-R207910 and its (2R) 
isomer. 
The search for new entities to treat M. tuberculosis and related strains in all their 
forms led to quinoline nucleus, which constitutes an important class of heterocyclic 
compounds found in many synthetic and natural products with a wide variety of important 
pharmacological activities. R207910 (5a) (TMC 207) (Fig 2) is one such compound 
structurally dissimilar to isoniazid and rifampicin and consisting of diarylquinoline 
scaffold. This compound was developed at Johnson & Johnson Pharmaceutical Research 
and Development, and possesses a new mechanism of action based on the interaction with 
the enzyme adenosine triphosphate (ATP) synthase. It is active against both drug-resistant 
and drug-susceptible M. tuberculosis, as well as other mycobacterial species. It has a 
relatively longer half life in plasma and tissues, of nearly 24 h. The compound stops the 
energy production by acting on the proton pump of adenosine triphosphate (ATP) synthase 
of M. tuberculosis but not on other bacterial ATP systems, which explains its high 
specificity for mycobacteria. In the mouse model, 2-month treatment regimes containing 
R207910 and PZA led to sterilization, which shows the potential for reduction of treatment 
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time to two months. Its fascinating biological activity interested us to develop an 
asymmetric and practical synthesis of R207910.  
     
 
 
 
Figure 2 
According to our retrosynthetic analysis, 5a could be obtained from 6a in two steps 
(Scheme 1). The stereocenter at the tetrasubstituted carbon was introduced by chelation 
controlled Barbier type reaction. The enantiomerically enriched ketone 8 could be obtained 
by Sharpless asymmetric epoxidation followed by ring opening with PhMgBr. 
Retrosynthetic analysis of (2S) R207910. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1 
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Results and Discussion 
The synthesis commenced with a known intermediate 6-bromo-2-chloroquinoline-3-
carbaldehyde 10, prepared from 4-bromo-acetanilide using a modified Vilsmeier-Haack 
reagent. It was subjected to Horner-Wadsworth-Emmons olefination using lithium enolate 
of the phosphonate [(OEt)2 P(O)CH2CO2Et] to afford α,β-unsaturated ester 11 in 89 % 
yield with complete E-selectivity. Reduction of compound 11 with DIBAL-H at 0 
o
C 
furnished allyl alcohol 12. Reaction of 12 with sodium methoxide gave 2-methoxy 
derivative 13.
 
 
 
 
 
 
 
 
 
 
 
Scheme 2 
Reagents and conditions: (a) (EtO)2P(O)-CH2CO2Et, LiHMDS, THF, 0 
o
C-rt, 2 h, 89 %; (b) DIBAL-H, 
CH2Cl2, 0 
o
C-rt, 2 h, 84 %; (c) NaOMe, MeOH, reflux, 8 h, 92 %; (d) (+)-DIPT, Ti(O
i
Pr)4, TBHP, CH2Cl2, 
−20 oC, 4 h, 86 %; (e) PhMgBr, CuCN, THF, −40 oC, 4 h, 86 %. 
The next operation was the Sharpless asymmetric epoxidation
 
which was carried out 
with (+)-DIPT, Ti(O
i
Pr)4, TBHP at −20 
o
C to afford epoxy alcohol 9 in 86 % yield (95 % 
ee). Subsequent exposure of the epoxide to PhMgBr in the presence of CuCN furnished 
diol 14 in 86 % yield (Scheme 2).
 
Diol 14 was oxidatively cleaved with NaIO4 
impregnated over silica gel to furnish aldehyde 15. The crude aldehyde was treated with 1-
naphthylmagnesium bromide to obtain secondary alcohol 16 as a mixture of isomers which 
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on oxidation with Dess-Martin periodinane afforded the keto derivative 8 in 81 % yield 
with high enantiomeric purity (95% ee). Our next concern was to construct the 
tetrasubstituted carbon center through allylation of carbonyl group present in 8. Our 
attempts to introduce the tetrasubstituted carbon through conventional nucleophiles like 
allylmagnesium, allylaluminium, allylindium, allylboronate, and allylstannane derivatives 
were not successful. A recent development of solvent free addition reaction of allylzinc 
bromide to carbonyl compound attracted our attention in this regard. Thus, with a slight 
modification compound 8 was treated with allylzinc bromide in the presence of 
CuBr.Me2S in THF to afford an inseparable mixture of required homoallyl alcohol 7a and 
7b in almost equal amounts of diastereomers (by HPLC) (Scheme 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3 
Reagents and conditions: (a) NaIO4, CH2Cl2, 0 
o
C-rt, 1 h, 98 %; (b) 1-naphthylmagnesium bromide, Et2O, 0 
o
C, 1 h, 92 %; (c) DMP, CH2Cl2, 3 h, 87%; (d) Allylzinc bromide, CuBr.DMS, THF, rt, 1 h, 90 %. 
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The diastereomers were separated by preparative HPLC (Pheonomenex Luna-C18 
(250x10mm, 10µ), ACN/water 9/1, flow 1.5 mL, detection- DAD): tR 10.0 min (syn) and 
9.25 min (anti). Both the diastereomers were subjected to a sequence of routine steps 
individually to end up in final compounds. Thus Oxidative cleavage
 
of olefin using OsO4-
NaIO4 in the presence of 2,6-lutidine afforded aldehyde 17a, which was treated with 
NaBH4 in methanol at 0 
o
C to obtain the diol 6a in 82% yield over two steps. Finally, O-
mesylation followed by displacement of the mesylate group in 18a with dimethylamine 
furnished (2S)-R207910 (5a) in 79% yield over two steps (Scheme 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4 
Reagents and conditions: (a) NaIO4, 2,6-lutidine, OsO4, dioxane:H2O (3:1), rt, 2 h; (b) NaBH4, MeOH, 0 
o
C-rt, 82 % (over two steps); (c) MsCl, Et3N, CH2Cl2, 0 
o
C-rt, 3 h, 88 %; (d) Me2NH, THF, 45 
o
C, 24  h, 90 
%. 
Abstract 
 
VII 
 
The spectral and analytical data of 5a ([α]D
25
 −165.2 (c = 0.8, DMF); ref.12: ([α]D
25
 
−166.98 (c = 0.5, DMF) was in good agreement with the reported data. The same set of 
reactions was performed on the other diastereomer (7b) to furnish (2R)-R207910 (5b) 
which was also in good agreement with the literature data. 
 
          
 
 
In a more practical approach the diastereomeric mixture (7a & 7b) obtained in the 
allylation step was carried to the final step with the same set of reaction protocol and the 
viability of chromatographic separation at the final stage has been tested. To our 
satisfaction the products were separable easily by silica gel column chromatography (ethyl 
acetate:hexane = 1:6). In fact this approach is operationally simple and amenable for scale 
up at affordable cost. 
 
 
 
 
In conclusion the synthesis of (2S)-R207910 (5a) and (2R)-R207910 (5b) was 
achieved in an overall yield of 12 % each in 10 steps. The key steps involved are Sharpless 
asymmetric epoxidation, regioselective epoxide opening and modified allylzinc bromide 
addition.  
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Chapter II: Asymmetric synthesis of aza (-)-Diospongin A as an iNOS inducer. 
Introduction: 
Nature has been the rich source of bioactive natural products and has laid basis for 
drug leads and new medicines since pre-historical era. Nearly half of the currently used 
drugs are of natural product origin derived either directly or designed based on 
pharmacophore.
 
However the structural complexity, paucity, side effects of, these 
pharmacologically active natural compounds has set limitations to use them as drug 
candidates. Thus modification of bioactive natural products to structurally similar synthetic 
analogues with minimum molecular complexity while retaining pharmacological activity 
and reduced side effects has gained importance over time. In this context we chose to 
prepare aza-analogue of diospongin-A (1a). 
 Diospongins 1a and 1b are a new family of diaryl heptanoids, which were isolated 
from the rhizomes of Dioscorea spongiosa in 2004 by Kadota et al. They are known to 
exhibit potent anti-osteoporotic activity in a bone organ culture. The structure of the 
diospongins containing a tetrahydropyran ring with two phenyl groups and three 
asymmetric centres is a tunable scaffold for the synthesis of various analogues. Our 
interest in the synthesis of bio-active molecules and their analogues has directed us 
towards the synthesis of diospongin analogues. Replacing the oxygen atom of the pyran 
ring in diospongin-A (1a) with nitrogen atom has resulted in the substituted piperidine ring 
of aza diospongin-A (2) whose biological activity was evaluated otherwise in the induction 
of inducible nitric oxide synthase (iNOS) enzyme and was found to be better when 
compared to its natural counterpart (Fig 3).  
 
 
 
 
 
 
Figure 3 
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Our retrosynthetic analysis led us to consider the key synthon to be 3 which could be 
synthesized easily from cross metathesis between phenyl vinyl ketone (9) and 4 which in 
turn could be obtained from a known intermediate (R)-1-Phenyl-3-buten-1-ol (5) (Scheme 
5).  
 
 
  
 
 
 
 
Scheme 5 
Results and discussion 
The synthesis began with (R)-1-Phenyl-3-buten-1-ol (5), which can be readily 
obtained from benzaldehyde via a Keck allylation. Alcohol 5 underwent Mitsunobu 
inversion with hydrazoic acid to provide azide 6 in 54% yield. The reduction of the azide 
functionality to an amine using LiAlH4 followed by protection of the primary amine with 
(Boc)2O afforded the protected homoallyl amine 7. To prepare the precursor for olefin 
cross-metathesis, the terminal olefin of protected homoallyl amine 7 was subjected to 
dihydroxylation followed by periodate cleavage to give aldehyde 8, which was 
immediately treated with allyl bromide in the presence of zinc. The allylation of aldehyde 
8 provided a mixture of diastereomers 4a and 4b in a 1:1 ratio, which were separated by 
column chromatography (EtOAc/Hexane: 3:17). The required isomer 1, 3-amino alcohol 
4a was submitted to olefin cross-metathesis with phenyl vinyl ketone (9) using Grubb’s 
2nd generation catalyst 10 (20 mol %) in dichloromethane. The reaction proceeded in 
excellent yield of the enone product 3, which was ready for aza-Michael addition reaction. 
As expected, amino enone 3 underwent Boc-deprotection followed by aza-Michael 
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reaction in one-pot to afford the target product, aza-diospongin A (2) in 96% yield (with 
99% enantiomeric purity) with the exclusive formation of cis-isomer (Scheme 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 6 
Reagents and conditions: (a) HN3, DIAD, TPP, benzene, rt, 3 h, 54%; (b) (i) LiAlH4, THF, 0 
o
C to rt, 1 h, 
(ii) (Boc)2O, 3 h, 90% (for two steps); (c) (i) NMO, OsO4 (cat), acetone–water (4:1), rt, overnight, (ii) NaIO4, 
THF, rt, 15 min, 95% (for two steps); (d) Allyl bromide, Zn, DMF, rt, 30 min, 70%.(e) 9, 10 (20 mol %), 
CH2Cl2, rt, 1 h, 70%; (f) TFA, CH2Cl2, 0 
o
C, 5 h, 96%. 
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The structure of the product was confirmed by IR, Mass, 
1
H NMR and 
13
C NMR 
spectroscopic data. The cis-configuration of 2,6-substituents was confirmed by nOe 
studies. 
A biological profile of this analogue was also evaluated towards the induction of 
inducible nitric oxide synthase. Table 1 clearly illustrates that 2 showed the best induction 
of inducible nitric oxide synthase/nitric oxide synthase 2 (iNOS) at 1 µM. The decreased 
biological effect observed at 10 µM might be related to the cytotoxic properties of 2. At the 
same time, the compound failed to elicit any detectable increase in the immunostimulatory 
potential at 0.1 µM demonstrating the requirement of minimum threshold concentration 
required for the transcriptional activation of iNOS gene. It might be possible to argue that 
the immunomodulatory potential of compound 2, which maintains improved bioactivity 
while showing reduced levels of cellular toxicity when compared to 1a, is superior and can 
be enhanced by synthesizing the corresponding analogues. The table next illustrates the 
quantitative responses of the two compounds tested towards the induction of inducible 
nitric oxide synthase (iNOS). 
Compound name  
Dose tested 
(µM) 
Nitrite (mM) 
produced 
Fold induction with respect to 
control 
2 10 8.88 1.605786618 
  1 24.65 4.457504521 
  0.1 16.4 2.965641953 
1a 10 8.81 1.593128391 
  1 13.44 2.430379747 
  0.1 11.79 2.132007233 
IFN-γ   12.8 2.314647378 
LPS+IFN-γ   60.93 11.01808318 
Controls   11.01 1.990958409 
 Controls DMSO   5.53 1 
Table 1: Nitrite production and corresponding fold activation of compounds 2 and 1a. Cells were 
treated with 1ng/mL IFNγ in order to prime the cells before treatment with compounds. 
Abbreviations: DMSO: Dimethyl Sulfoxide; iNOS/NOS2: inducible Nitric Oxide Synthase/Nitric 
Oxide Synthase 2; LPS: Lipopolysaccharide; IFNγ: Interferon gamma; ng: Nano gram.  
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In conclusion, the aza-derivative of (-)-Diospongin A has been synthesized with the 
key steps being Mitsunobu inversion, cross olefin metathesis and intramolecular aza-
Michael addition reactions. The, aza-Diospongin A was tested towards the induction of the 
inducible nitric oxide synthase enzyme by comparison with the natural Diospongin-A and 
it was found that the aza-analogue showed a better activity when compared to the natural 
one. 
 
Chapter III: Palladium-catalyzed addition of hydroxylamine derivatives to Baylis–
Hillman acetate adducts. 
Introduction:  
The carbon-carbon, carbon-halogen, carbon-heteroatom bond forming process are 
invariably the fundamental and most important synthetic tools for synthetic community in 
the construction of complex natural products, functional advanced materials,  
pharmaceutical lead compounds, and other high-value commercial products. Among many 
known and available methods for these bonds forming processes allylic substitution was 
well explored in terms of transition metal catalysis. Palladium-catalysed allylic substitution 
has been used in a wide variety of synthetically useful reactions involving various 
nucleophiles. However the use of hydroxylamines as oxygen atom (aminoxy equivalent) 
nucleophiles for allylic substitution reactions has been studied limitedly. The products of 
Baylis–Hillman reactions (BH adducts) are multifunctional allylic alcohols and have been 
used as precursors in synthesizing several useful compounds. In particular, the acetates of 
Baylis–Hillman adducts have proved to be very useful synthons for addition reactions with 
different nucleophilic reagents. In continuation of our interest in the reactions involving 
Baylis–Hillman adducts, we studied the nucleophilic addition of hydroxylamine 
derivatives to Baylis–Hillman acetate adducts in the presence of 10 mol % Pd(PPh3)4 
(Scheme 7). The products obtained also serve as intermediates for making useful allyloxy 
amines/aminoxy esters and their derivatives. 
We first examined the reaction of N-hydroxyphthalimide 1b with Baylis–Hillman 
adduct 1a in the presence of 10 mol % Pd(PPh3)4 in acetonitrile at room temperature to 
afford the corresponding allyloxy phthalimide 1c. The reaction was complete in 1 h and  
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Scheme 7 
product 1c was obtained in 80% yield with exclusive (E)-selectivity (entry 1). The 
stereochemistry of the product was established based on extensive 2D NMR studies. In the 
absence of a catalyst, no reaction occurred even at reflux. Next, the reaction of Baylis–
Hillman acetate adduct 2a, derived from acrylonitrile, with N-hydroxyphthalimide under 
similar reaction conditions gave the corresponding product, 2c in 71% yield with exclusive 
(E)-selectivity (entry 2). To prove the generality of the method, other Baylis–Hillman 
acetate adducts with N-hydroxyphthalimide 1b and succinimide 2b were engaged in this 
method (entries 3–11). The results are summarized in Table 1. In all cases, the reaction 
proceeded smoothly and afforded the products in reasonably good yields with good 
selectivity. As shown in Table 1, Baylis–Hillman acetate adducts derived from ethyl 
acrylate gave the corresponding products having the aryl group trans to the ester, whereas 
the adducts derived from acrylonitrile gave products having the aryl group cis to the nitrile. 
The olefin geometry was established based on 
1
H and 
13
C NMR chemical shifts and by 
comparison with literature values. However, reaction with N-Boc-hydroxylamine and N-
benzyl hydroxylamine gave low yields of the desired products with (E)-selectivity (entries 
12 and 13).  
We also investigated the transformations of 1c into useful substituted allyloxy 
amine/aminoxy ester 1d and its derivatives 1e and 1f (Scheme 8). Further applications of 
these products to prepare pseudo-γ-amino acids are underway. 
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Scheme 8 
 
In conclusion, we have developed a palladium-catalysed addition of hydroxylamine 
derivatives to Baylis–Hillman acetate adducts. The selective formation of substituted 
allyloxy amine products was observed and these products may find use in organic 
synthesis. 
 
 
